Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma

Detalles Bibliográficos
Autores principales: Mino, T, Mihara, K, Yoshida, T, Takihara, Y, Ichinohe, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183774/
https://www.ncbi.nlm.nih.gov/pubmed/25215661
http://dx.doi.org/10.1038/bcj.2014.65
_version_ 1782337746475417600
author Mino, T
Mihara, K
Yoshida, T
Takihara, Y
Ichinohe, T
author_facet Mino, T
Mihara, K
Yoshida, T
Takihara, Y
Ichinohe, T
author_sort Mino, T
collection PubMed
description
format Online
Article
Text
id pubmed-4183774
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41837742014-10-03 Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma Mino, T Mihara, K Yoshida, T Takihara, Y Ichinohe, T Blood Cancer J Letter to the Editor Nature Publishing Group 2014-09 2014-09-12 /pmc/articles/PMC4183774/ /pubmed/25215661 http://dx.doi.org/10.1038/bcj.2014.65 Text en Copyright © 2014 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Mino, T
Mihara, K
Yoshida, T
Takihara, Y
Ichinohe, T
Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
title Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
title_full Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
title_fullStr Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
title_full_unstemmed Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
title_short Monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
title_sort monthly administration of rituximab is useful for patients with ocular adnexal mucosa-associated lymphoid tissue lymphoma
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183774/
https://www.ncbi.nlm.nih.gov/pubmed/25215661
http://dx.doi.org/10.1038/bcj.2014.65
work_keys_str_mv AT minot monthlyadministrationofrituximabisusefulforpatientswithocularadnexalmucosaassociatedlymphoidtissuelymphoma
AT miharak monthlyadministrationofrituximabisusefulforpatientswithocularadnexalmucosaassociatedlymphoidtissuelymphoma
AT yoshidat monthlyadministrationofrituximabisusefulforpatientswithocularadnexalmucosaassociatedlymphoidtissuelymphoma
AT takiharay monthlyadministrationofrituximabisusefulforpatientswithocularadnexalmucosaassociatedlymphoidtissuelymphoma
AT ichinohet monthlyadministrationofrituximabisusefulforpatientswithocularadnexalmucosaassociatedlymphoidtissuelymphoma

Ejemplares similares